Fundz

Gho Capital Invests In Roslinct, A Leading Cell Therapy Cdmo

Jan 11, 2022

Round Type

Funding Round

EdinburghManufacturingConsumer Goods

Description

Global Healthcare Opportunities, or GHO Capital Partners LLP, the European specialist investor in global healthcare, announces their investment in RoslinCT, a leading Contract Development and Manufacturing Organization (CDMO) focused on advanced cell therapies.

Quick answer

RoslinCT raised an undisclosed amount in a Funding Round round, dated January 11, 2022. RoslinCT is based in Edinburgh, Scotland, United Kingdom.

How much did RoslinCT raise?
RoslinCT raised an undisclosed amount in a Funding Round round on January 11, 2022.
What does RoslinCT do?
RoslinCT is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for companies developing cell-based therapeutic products.
Where is RoslinCT based and how big is it?
RoslinCT is based in Edinburgh, Scotland, United Kingdom. Fundz records about 201 employees.
Who are the decision-makers at RoslinCT?
Fundz holds 1 contact at RoslinCT. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Consumer Goods and Manufacturing around the same time

Companies in the same sectors as RoslinCT that raised within 45 days of this round, from Fundz verified event records.

  • Hadrian raised $36M on January 7, 2022.
  • Ambercycle raised $22M (Funding Round) on January 4, 2022.
  • Liquid Death’s raised $75M (Funding Round) on January 4, 2022.
  • Supergoop! raised an undisclosed amount on December 20, 2021.
  • Adden Energy raised $5.1M on February 25, 2022.
  • RealWear raised $20M on February 25, 2022.

Who to call at RoslinCT, and when

A new round usually means RoslinCT is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day RoslinCT raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at RoslinCT, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at RoslinCT. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

RoslinCT

Location

Edinburgh, Scotland, United Kingdom

About

RoslinCT is a leading UK Cell Therapy Contract Development and Manufacturing Organisation (CDMO) focused on providing services for companies developing cell-based therapeutic products. Originally founded in 2006 as a spin-out from the Roslin Institute, we built on the broad range of scientific expertise available in the field of cell biology.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment RoslinCT raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for RoslinCT's next move

See what Strategic adds

RoslinCT raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.